Journal News

Review delves into proximity proteomics

Laurel Oldach
April 20, 2020

In a recent review article in Molecular & Cellular Proteomics, Payman Samavarchi–Tehrani and colleagues in the Gingras lab at Sinai Health Systems and the University of Toronto offer an introduction to proximity-dependent biotinylation, a key first step in proximity proteomics. The authors give researchers who are new to the field information about the natural history of biotinylation enzymes. They also offer insights into the mechanisms of these enzymes and new perspectives on future proximity proteomics experiments.

Traditional proteomics can provide information about the quantitative contents of a cell or tissue, but it sacrifices much information on the spatial organization of proteins within cells. Since protein activity often depends on location and interactions with other proteins, researchers have developed approaches such as proximity proteomics to obtain information about the environs of a protein of interest. Proximity proteomics methods developed in the past 10 years depend on fusing the protein of interest to an enzyme that will label nearby proteins with a chemical tag that then can be purified. After purification, mass spectrometry identifies the tagged proteins.

Most often, the chemical tag is biotin, a cofactor that is key to carboxylase enzyme activity in several metabolic pathways. Two types of enzyme are used for proximity-dependent biotinylation: peroxidases, used for methods such as APEX, and biotin ligases, used for methods such as BioID.

Proxprotimage-835x195.jpg
Samavarchi–Tehrani et al./MCP
A schematic diagram shows the proximity proteomics workflow. A bait protein is tagged with a biotinylation enzyme (center of concentric circles), which allows for covalent labeling of proteins in its vicinity with a reactive biotin intermediate. Then the researcher lyses the cells and uses streptavidin to extract biotin-tagged proteins, digests those proteins and uses mass spectrometry to determine their identity.

Ordinarily, biotin ligases append biotin to the carboxylases that need it as a cofactor. Biotin ligases found in cells have high specificity for their substrate proteins, but certain mutations reduce that specificity by decreasing the ligase enzyme’s affinity for a reactive intermediate. Such mutants lose their grip on the cofactor and can release a reactive biotin that can bind the next amine group it encounters — often on a nearby protein. When researchers pull down biotin after this reaction occurs, they can determine what proteins were localized in the neighborhood of the biotin ligase and, by extension, the protein it was tethered to.

The second enzyme family, the peroxidases, evolved to convert hydrogen peroxide to water by redox chemistry. In the presence of a biotin–phenol substrate and hydrogen peroxide, they can make a short-lived free radical that reacts with certain amino acid side chains, once again tagging nearby proteins for later identification.

As proximity proteomics has grown in popularity, both types of enzyme have been the targets of extensive engineering and molecular evolution to coax them toward the activity profiles users want. The authors review the available enzymes and discuss experimental design considerations, such as choice of control conditions and how to get rid of what they call “frequent flyer” proteins that often are isolated nonspecifically.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Mapping fentanyl’s cellular footprint
Journal News

Mapping fentanyl’s cellular footprint

Dec. 4, 2025

Using a new imaging method, researchers at State University of New York at Buffalo traced fentanyl’s effects inside brain immune cells, revealing how the drug alters lipid droplets, pointing to new paths for addiction diagnostics.

Designing life’s building blocks with AI
Profile

Designing life’s building blocks with AI

Dec. 2, 2025

Tanja Kortemme, a professor at the University of California, San Francisco, will discuss her research using computational biology to engineer proteins at the 2026 ASBMB Annual Meeting.

Cholesterol as a novel biomarker for Fragile X syndrome
Journal News

Cholesterol as a novel biomarker for Fragile X syndrome

Nov. 28, 2025

Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.

How lipid metabolism shapes sperm development
Journal News

How lipid metabolism shapes sperm development

Nov. 26, 2025

Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.

Mass spec method captures proteins in native membranes
Journal News

Mass spec method captures proteins in native membranes

Nov. 25, 2025

Yale scientists developed a mass spec protocol that keeps proteins in their native environment, detects intact protein complexes and tracks drug binding, offering a clearer view of membrane biology.

Laser-assisted cryoEM method preserves protein structure
Journal News

Laser-assisted cryoEM method preserves protein structure

Nov. 25, 2025

University of Wisconsin–Madison researchers devised a method that prevents protein compaction during cryoEM prep, restoring natural structure for mass spec studies. The approach could expand high-resolution imaging to more complex protein systems.